Yüklüyor......
Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
Pancreatic cancer is one of the deadliest cancers, ranking fourth among cancer-related deaths. Despite all the major molecular advances and treatment breakthroughs, mainly targeted therapies, the cornerstone treatment of metastatic pancreatic cancer (mPC) remains cytotoxic chemotherapy. In 2016, mor...
Kaydedildi:
| Yayımlandı: | World J Gastroenterol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5155171/ https://ncbi.nlm.nih.gov/pubmed/28028360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i46.10124 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|